(+)-dexrazoxane decreases expression ISO RGD:737089 6480464 Dexrazoxane results in decreased expression of ACSL1 mRNA CTD PMID:26873546 (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACSL1 mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate decreases expression EXP 6480464 epigallocatechin gallate results in decreased expression of ACSL1 mRNA CTD PMID:16988119 (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE decreases expression EXP 6480464 Topotecan results in decreased expression of ACSL1 mRNA CTD PMID:25729387 (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ACSL1 mRNA CTD PMID:25729387 (S)-nicotine increases splicing ISO RGD:1342971 6480464 Nicotine results in increased splicing of ACSL1 mRNA alternative form CTD PMID:23825647 1,1-dichloroethene decreases expression ISO RGD:737089 6480464 vinylidene chloride results in decreased expression of ACSL1 mRNA CTD PMID:26682919 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of ACSL1 mRNA CTD PMID:17522070 more ... 17alpha-ethynylestradiol decreases expression ISO RGD:737089 6480464 Ethinyl Estradiol results in decreased expression of ACSL1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of ACSL1 mRNA CTD PMID:17108234 17alpha-ethynylestradiol multiple interactions ISO RGD:737089 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of ACSL1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO RGD:737089 6480464 Ethinyl Estradiol affects the expression of ACSL1 mRNA CTD PMID:17555576 17beta-estradiol multiple interactions ISO RGD:1342971 6480464 [Estradiol co-treated with Progesterone] results in increased expression of ACSL1 mRNA more ... CTD PMID:17404688 more ... 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propanoic acid increases expression EXP 6480464 2 more ... CTD PMID:30920876 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1342971 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ACSL1 gene] CTD PMID:28681081 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1342971 6480464 Tetrachlorodibenzodioxin results in decreased expression of ACSL1 mRNA CTD PMID:20106945 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:737089 6480464 Tetrachlorodibenzodioxin results in decreased expression of ACSL1 mRNA CTD PMID:19770486 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:737089 6480464 Tetrachlorodibenzodioxin affects the expression of ACSL1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ACSL1 mRNA CTD PMID:18796159 , PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:737089 6480464 Tetrachlorodibenzodioxin results in increased expression of ACSL1 mRNA CTD PMID:17035482 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:737089 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of ACSL1 mRNA, Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of ACSL1 mRNA] CTD PMID:16054899 , PMID:17942748 2,3-dimethoxynaphthalene-1,4-dione decreases expression ISO RGD:1342971 6480464 2 more ... CTD PMID:17547211 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of ACSL1 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of ACSL1 mRNA CTD PMID:21346803 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:737089 6480464 3 more ... CTD PMID:19467301 3,4-methylenedioxymethamphetamine increases expression ISO RGD:737089 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of ACSL1 mRNA CTD PMID:20188158 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of ACSL1 protein CTD PMID:26597043 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin analog results in decreased expression of ACSL1 protein CTD PMID:26597043 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:737089 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ACSL1 mRNA more ... CTD PMID:16054899 , PMID:23428407 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1342971 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ACSL1 mRNA more ... CTD PMID:28628672 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of ACSL1 mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane increases expression ISO RGD:737089 6480464 4, 4'-diaminodiphenylmethane results in increased expression of ACSL1 mRNA CTD PMID:18648102 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions ISO RGD:1342971 6480464 [Benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of ACSL1 mRNA CTD PMID:20146248 4-nitroquinoline N-oxide decreases expression ISO RGD:737089 6480464 4-Nitroquinoline-1-oxide results in decreased expression of ACSL1 mRNA CTD PMID:22561872 5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide decreases expression ISO RGD:1342971 6480464 Niclosamide results in decreased expression of ACSL1 mRNA CTD PMID:22576131 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of ACSL1 mRNA CTD PMID:24780913 aflatoxin B1 decreases expression ISO RGD:1342971 6480464 Aflatoxin B1 results in decreased expression of ACSL1 mRNA CTD PMID:22100608 , PMID:27153756 aflatoxin B2 increases methylation ISO RGD:1342971 6480464 aflatoxin B2 results in increased methylation of ACSL1 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1342971 6480464 Tretinoin results in increased expression of ACSL1 mRNA CTD PMID:21934132 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ACSL1 mRNA CTD PMID:16483693 antimony(0) decreases expression ISO RGD:1342971 6480464 Antimony results in decreased expression of ACSL1 mRNA CTD PMID:17547211 antimony(3+) decreases expression ISO RGD:1342971 6480464 Antimony results in decreased expression of ACSL1 mRNA CTD PMID:17547211 aristolochic acid multiple interactions EXP 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in decreased expression of ACSL1 mRNA CTD PMID:23912714 Aroclor 1254 decreases expression ISO RGD:737089 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ACSL1 mRNA CTD PMID:23650126 arsenite(3-) increases expression ISO RGD:1342971 6480464 arsenite results in increased expression of ACSL1 mRNA CTD PMID:23974009 benzene affects expression ISO RGD:1342971 6480464 Benzene affects the expression of ACSL1 mRNA CTD PMID:21147609 , PMID:30300410 benzo[a]pyrene multiple interactions ISO RGD:1342971 6480464 [Benzo(a)pyrene co-treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone] results in increased expression of ACSL1 mRNA CTD PMID:20146248 benzo[a]pyrene decreases expression ISO RGD:1342971 6480464 Benzo(a)pyrene results in decreased expression of ACSL1 mRNA CTD PMID:20106945 more ... benzo[a]pyrene decreases expression ISO RGD:737089 6480464 Benzo(a)pyrene results in decreased expression of ACSL1 mRNA CTD PMID:19770486 Benzo[k]fluoranthene decreases expression ISO RGD:737089 6480464 benzo(k)fluoranthene results in decreased expression of ACSL1 mRNA CTD PMID:26377693 beta-D-glucosamine 6-sulfate decreases expression ISO RGD:737089 6480464 glucosamine 6-O-sulfate results in decreased expression of ACSL1 mRNA CTD PMID:19520133 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of ACSL1 mRNA CTD PMID:23292798 bezafibrate multiple interactions ISO RGD:737089 6480464 Butyrates promotes the reaction [Bezafibrate results in increased expression of ACSL1 mRNA], PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of ACSL1 mRNA] CTD PMID:19124612 , PMID:22338096 bezafibrate increases expression ISO RGD:737089 6480464 Bezafibrate results in increased expression of ACSL1 mRNA CTD PMID:17118139 more ... bezafibrate increases expression ISO RGD:1342971 6480464 Bezafibrate results in increased expression of ACSL1 mRNA CTD PMID:19682441 , PMID:21640707 bicalutamide increases expression ISO RGD:1342971 6480464 bicalutamide results in increased expression of ACSL1 mRNA CTD PMID:15790403 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of ACSL1 mRNA CTD PMID:22672789 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1342971 6480464 Diethylhexyl Phthalate results in decreased expression of ACSL1 protein CTD PMID:31163220 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1342971 6480464 Diethylhexyl Phthalate results in increased expression of ACSL1 mRNA CTD PMID:31163220 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ACSL1 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:1342971 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ACSL1 mRNA CTD PMID:28628672 bisphenol A affects methylation ISO RGD:737089 6480464 bisphenol A affects the methylation of ACSL1 promoter CTD PMID:27334623 bisphenol F multiple interactions ISO RGD:1342971 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACSL1 mRNA CTD PMID:28628672 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of ACSL1 mRNA CTD PMID:12628495 butan-1-ol multiple interactions ISO RGD:1342971 6480464 [[Gasoline co-treated with 1-Butanol] results in increased chemical synthesis of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ACSL1 mRNA CTD PMID:29432896 cadmium atom increases oxidation ISO RGD:737089 6480464 Cadmium results in increased oxidation of ACSL1 protein CTD PMID:24496640 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of ACSL1 promoter CTD PMID:22457795 cadmium dichloride increases expression ISO RGD:1342971 6480464 Cadmium Chloride results in increased expression of ACSL1 mRNA CTD PMID:25596134 carbamazepine affects expression ISO RGD:1342971 6480464 Carbamazepine affects the expression of ACSL1 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:737089 6480464 Nanotubes, Carbon analog results in decreased expression of ACSL1 mRNA, Nanotubes, Carbon results in decreased expression of ACSL1 mRNA CTD PMID:25554681 , PMID:25620056 chloroacetaldehyde decreases expression ISO RGD:1342971 6480464 chloroacetaldehyde results in decreased expression of ACSL1 mRNA CTD PMID:25596134 chloroform decreases expression EXP 6480464 Chloroform results in decreased expression of ACSL1 mRNA CTD PMID:17522070 choline increases expression ISO RGD:737089 6480464 Choline deficiency results in increased expression of ACSL1 mRNA CTD PMID:25178843 chromium atom decreases expression ISO RGD:1342971 6480464 Chromium results in decreased expression of ACSL1 mRNA CTD PMID:17547211 chromium(3+) decreases expression ISO RGD:1342971 6480464 Chromium results in decreased expression of ACSL1 mRNA CTD PMID:17547211 ciglitazone multiple interactions ISO RGD:1342971 6480464 [ciglitazone binds to PPARG protein] which results in increased expression of ACSL1 mRNA CTD PMID:16197558 ciprofibrate increases expression EXP 6480464 ciprofibrate results in increased expression of ACSL1 mRNA CTD PMID:27225895 cisplatin increases expression ISO RGD:1342971 6480464 Cisplatin results in increased expression of ACSL1 mRNA CTD PMID:27594783 cisplatin decreases expression ISO RGD:1342971 6480464 Cisplatin results in decreased expression of ACSL1 mRNA CTD PMID:25596134 clodronic acid decreases expression ISO RGD:1342971 6480464 Clodronic Acid results in decreased expression of ACSL1 mRNA CTD PMID:25596134 clofibrate multiple interactions ISO RGD:737089 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ACSL1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ACSL1 mRNA] CTD PMID:17585979 clofibrate increases expression ISO RGD:737089 6480464 Clofibrate results in increased expression of ACSL1 mRNA CTD PMID:23811191 , PMID:30629241 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of ACSL1 protein CTD PMID:20118634 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of ACSL1 mRNA, Clofibrate results in increased expression of ACSL1 protein CTD PMID:12851107 , PMID:16470657 Clofop multiple interactions ISO RGD:1342971 6480464 [fenofibric acid binds to PPARA protein] which results in increased expression of ACSL1 mRNA CTD PMID:16197558 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of ACSL1 mRNA CTD PMID:11078357 copper atom multiple interactions ISO RGD:1342971 6480464 [NSC 689534 binds to Copper] which results in decreased expression of ACSL1 mRNA CTD PMID:20971185 copper atom decreases expression EXP 6480464 Copper deficiency results in decreased expression of ACSL1 mRNA, Copper results in decreased expression of ACSL1 mRNA CTD PMID:19821111 , PMID:22465980 copper(0) multiple interactions ISO RGD:1342971 6480464 [NSC 689534 binds to Copper] which results in decreased expression of ACSL1 mRNA CTD PMID:20971185 copper(0) decreases expression EXP 6480464 Copper deficiency results in decreased expression of ACSL1 mRNA, Copper results in decreased expression of ACSL1 mRNA CTD PMID:19821111 , PMID:22465980 copper(2+) multiple interactions ISO RGD:1342971 6480464 [NSC 689534 binds to Copper] which results in decreased expression of ACSL1 mRNA CTD PMID:20971185 copper(2+) decreases expression EXP 6480464 Copper deficiency results in decreased expression of ACSL1 mRNA, Copper results in decreased expression of ACSL1 mRNA CTD PMID:19821111 , PMID:22465980 copper(II) sulfate increases expression ISO RGD:1342971 6480464 Copper Sulfate results in increased expression of ACSL1 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:1342971 6480464 Cyclosporine results in decreased expression of ACSL1 mRNA CTD PMID:20106945 cyclosporin A decreases methylation ISO RGD:1342971 6480464 Cyclosporine results in decreased methylation of ACSL1 promoter CTD PMID:27989131 cyclosporin A affects expression ISO RGD:1342971 6480464 Cyclosporine affects the expression of ACSL1 mRNA CTD PMID:25596134 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of ACSL1 mRNA CTD PMID:25596134 cyclosporin A increases expression ISO RGD:1342971 6480464 Cyclosporine results in increased expression of ACSL1 mRNA CTD PMID:25562108 cyclosporin A decreases expression ISO RGD:737089 6480464 Cyclosporine results in decreased expression of ACSL1 mRNA CTD PMID:19770486 cyproconazole decreases expression ISO RGD:737089 6480464 cyproconazole results in decreased expression of ACSL1 mRNA CTD PMID:22334560 dehydroepiandrosterone increases expression EXP 6480464 Dehydroepiandrosterone results in increased expression of ACSL1 mRNA CTD PMID:16940010 dexamethasone multiple interactions ISO RGD:737089 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ACSL1 mRNA more ... CTD PMID:16054899 , PMID:23428407 dexamethasone multiple interactions ISO RGD:1342971 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ACSL1 mRNA more ... CTD PMID:28628672 dexamethasone increases expression ISO RGD:1342971 6480464 Dexamethasone results in increased expression of ACSL1 mRNA CTD PMID:25047013 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of ACSL1 mRNA CTD PMID:17522070 dichlorine decreases expression EXP 6480464 Chlorine results in decreased expression of ACSL1 mRNA CTD PMID:18636392 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] affects the expression of ACSL1 mRNA CTD PMID:18636392 dichloroacetic acid increases expression ISO RGD:737089 6480464 Dichloroacetic Acid results in increased expression of ACSL1 mRNA CTD PMID:28962523 dioscin multiple interactions ISO RGD:737089 6480464 dioscin inhibits the reaction [Ethanol results in decreased expression of ACSL1 protein] CTD PMID:24146112 dioscin multiple interactions EXP 6480464 dioscin inhibits the reaction [Ethanol results in decreased expression of ACSL1 protein] CTD PMID:24146112 dioxygen increases expression ISO RGD:737089 6480464 Oxygen deficiency results in increased expression of ACSL1 mRNA CTD PMID:22629407 dioxygen increases expression ISO RGD:1342971 6480464 Oxygen deficiency results in increased expression of ACSL1 protein CTD PMID:26087400 dioxygen decreases expression ISO RGD:1342971 6480464 Oxygen deficiency results in decreased expression of ACSL1 mRNA CTD PMID:25596134 dioxygen multiple interactions ISO RGD:737089 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACSL1 mRNA, Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of ACSL1 mRNA] CTD PMID:22629407 , PMID:30529165 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate decreases expression ISO RGD:1342971 6480464 Antimony Potassium Tartrate results in decreased expression of ACSL1 mRNA CTD PMID:17547211 diuron decreases expression EXP 6480464 Diuron results in decreased expression of ACSL1 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:1342971 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of ACSL1 mRNA CTD PMID:19915844 doxorubicin decreases expression ISO RGD:1342971 6480464 Doxorubicin results in decreased expression of ACSL1 mRNA CTD PMID:29803840 doxorubicin decreases expression ISO RGD:737089 6480464 Doxorubicin results in decreased expression of ACSL1 mRNA CTD PMID:26873546 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of ACSL1 mRNA CTD PMID:29391264 entacapone affects binding EXP 6480464 entacapone binds to ACSL1 protein CTD PMID:19783845 entinostat increases expression ISO RGD:1342971 6480464 entinostat results in increased expression of ACSL1 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1342971 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL1 mRNA CTD PMID:27188386 epoxiconazole decreases expression ISO RGD:737089 6480464 epoxiconazole results in decreased expression of ACSL1 mRNA CTD PMID:22334560 erythromycin estolate decreases expression EXP 6480464 Erythromycin Estolate results in decreased expression of ACSL1 mRNA CTD PMID:17522070 ethanol increases expression EXP 6480464 Ethanol results in increased expression of ACSL1 mRNA, Ethanol results in increased expression of ACSL1 protein CTD PMID:15353170 , PMID:23200777 ethanol affects splicing ISO RGD:737089 6480464 Ethanol affects the splicing of ACSL1 mRNA CTD PMID:30319688 ethanol decreases expression ISO RGD:737089 6480464 Ethanol results in decreased expression of ACSL1 protein CTD PMID:24146112 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of ACSL1 mRNA, Ethanol results in decreased expression of ACSL1 protein CTD PMID:24146112 , PMID:26115886 ethanol multiple interactions EXP 6480464 dioscin inhibits the reaction [Ethanol results in decreased expression of ACSL1 protein] more ... CTD PMID:24146112 , PMID:26115886 ethanol multiple interactions ISO RGD:737089 6480464 [Zinc deficiency co-treated with Ethanol] results in increased expression of ACSL1 mRNA, dioscin inhibits the reaction [Ethanol results in decreased expression of ACSL1 protein] CTD PMID:24146112 , PMID:24155903 ethyl methanesulfonate decreases expression ISO RGD:1342971 6480464 Ethyl Methanesulfonate results in decreased expression of ACSL1 mRNA CTD PMID:23649840 fenofibrate increases expression ISO RGD:737089 6480464 Fenofibrate results in increased expression of ACSL1 mRNA, Fenofibrate results in increased expression of ACSL1 protein CTD PMID:17118139 , PMID:24752549 fenofibrate multiple interactions ISO RGD:737089 6480464 PPARA gene mutant form inhibits the reaction [Fenofibrate results in increased expression of ACSL1 mRNA], PPARA gene mutant form inhibits the reaction [Fenofibrate results in increased expression of ACSL1 protein] CTD PMID:24752549 fenofibrate multiple interactions ISO RGD:1342971 6480464 PPARA protein promotes the reaction [Fenofibrate results in increased expression of ACSL1 protein] CTD PMID:24752549 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of ACSL1 mRNA CTD PMID:10600944 , PMID:25596134 fenofibrate increases expression ISO RGD:1342971 6480464 Fenofibrate results in increased expression of ACSL1 mRNA, Fenofibrate results in increased expression of ACSL1 protein CTD PMID:24752549 , PMID:25596134 fenofibrate decreases expression EXP 6480464 Fenofibrate results in decreased expression of ACSL1 protein CTD PMID:20118634 fenofibrate affects expression EXP 6480464 Fenofibrate affects the expression of ACSL1 mRNA CTD PMID:20801182 fenoprofen increases metabolic processing EXP 6480464 ACSL1 protein results in increased metabolism of Fenoprofen CTD PMID:10725307 flutamide decreases expression ISO RGD:737089 6480464 Flutamide results in decreased expression of ACSL1 mRNA CTD PMID:17702527 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of ACSL1 mRNA CTD PMID:24136188 fumonisin B1 decreases expression ISO RGD:737089 6480464 fumonisin B1 results in decreased expression of ACSL1 mRNA CTD PMID:16221962 furan increases methylation EXP 6480464 furan results in increased methylation of ACSL1 gene CTD PMID:22079235 furan decreases expression EXP 6480464 furan results in decreased expression of ACSL1 mRNA CTD PMID:26194646 furan affects binding EXP 6480464 furan binds to ACSL1 protein CTD PMID:22240984 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of ACSL1 mRNA CTD PMID:22061828 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of ACSL1 mRNA CTD PMID:24136188 hexadecanoic acid multiple interactions ISO RGD:1342971 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of ACSL1 mRNA, [Palmitic Acid co-treated with Oleic Acid] affects the expression of ACSL1 mRNA CTD PMID:30547786 hydrogen peroxide affects expression ISO RGD:1342971 6480464 Hydrogen Peroxide affects the expression of ACSL1 mRNA CTD PMID:20044591 ibuprofen increases metabolic processing EXP 6480464 ACSL1 protein results in increased metabolism of Ibuprofen CTD PMID:10725307 ibuprofen increases expression EXP 6480464 Ibuprofen results in increased expression of ACSL1 mRNA CTD PMID:25596134 ibuprofen increases expression ISO RGD:1342971 6480464 Ibuprofen results in increased expression of ACSL1 mRNA CTD PMID:25596134 ifosfamide decreases expression ISO RGD:1342971 6480464 Ifosfamide results in decreased expression of ACSL1 mRNA CTD PMID:25596134 indometacin multiple interactions ISO RGD:1342971 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ACSL1 mRNA more ... CTD PMID:28628672 iron atom decreases expression EXP 6480464 Iron deficiency results in decreased expression of ACSL1 mRNA CTD PMID:19821111 iron(0) decreases expression EXP 6480464 Iron deficiency results in decreased expression of ACSL1 mRNA CTD PMID:19821111 linalool multiple interactions ISO RGD:737089 6480464 PPARA gene mutant form inhibits the reaction [linalool results in increased expression of ACSL1 mRNA], PPARA gene mutant form inhibits the reaction [linalool results in increased expression of ACSL1 protein] CTD PMID:24752549 linalool increases expression ISO RGD:1342971 6480464 linalool results in increased expression of ACSL1 mRNA, linalool results in increased expression of ACSL1 protein CTD PMID:24752549 linalool multiple interactions ISO RGD:1342971 6480464 PPARA protein promotes the reaction [linalool results in increased expression of ACSL1 protein] CTD PMID:24752549 linalool increases expression ISO RGD:737089 6480464 linalool results in increased expression of ACSL1 mRNA, linalool results in increased expression of ACSL1 protein CTD PMID:24752549 lithocholic acid decreases expression ISO RGD:737089 6480464 Lithocholic Acid results in decreased expression of ACSL1 mRNA CTD PMID:20359477 lithocholic acid multiple interactions ISO RGD:737089 6480464 Pregnenolone Carbonitrile inhibits the reaction [Lithocholic Acid results in decreased expression of ACSL1 mRNA] CTD PMID:20359477 medroxyprogesterone acetate increases expression ISO RGD:1342971 6480464 Medroxyprogesterone Acetate results in increased expression of ACSL1 mRNA CTD PMID:18497975 menadione affects expression ISO RGD:1342971 6480464 Vitamin K 3 affects the expression of ACSL1 mRNA CTD PMID:20044591 mercury atom decreases expression ISO RGD:1342971 6480464 Mercury results in decreased expression of ACSL1 mRNA CTD PMID:17547211 mercury dibromide multiple interactions ISO RGD:1342971 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL1 mRNA CTD PMID:27188386 mercury(0) decreases expression ISO RGD:1342971 6480464 Mercury results in decreased expression of ACSL1 mRNA CTD PMID:17547211 mercury(2+) decreases expression ISO RGD:1342971 6480464 Mercury results in decreased expression of ACSL1 mRNA CTD PMID:17547211 metformin decreases expression EXP 6480464 Metformin results in decreased expression of ACSL1 mRNA CTD PMID:25596134 methoxyacetic acid multiple interactions ISO RGD:1342971 6480464 methoxyacetic acid promotes the reaction [Promegestone results in increased expression of ACSL1 mRNA] CTD PMID:15103026 methyl methanesulfonate decreases expression ISO RGD:1342971 6480464 Methyl Methanesulfonate results in decreased expression of ACSL1 mRNA CTD PMID:23649840 Methylazoxymethanol acetate affects expression EXP 6480464 Methylazoxymethanol Acetate affects the expression of ACSL1 mRNA CTD PMID:28349193 methylmercury chloride increases expression ISO RGD:1342971 6480464 methylmercuric chloride results in increased expression of ACSL1 mRNA CTD PMID:28001369 mitomycin C affects response to substance ISO RGD:1342971 6480464 ACSL1 protein affects the susceptibility to Mitomycin CTD PMID:16217747 mono(2-ethylhexyl) phthalate increases expression ISO RGD:737089 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of ACSL1 protein CTD PMID:27384973 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of ACSL1 mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ACSL1 mRNA CTD PMID:28943392 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of ACSL1 mRNA CTD PMID:25380136 N-nitrosodimethylamine decreases expression ISO RGD:1342971 6480464 Dimethylnitrosamine results in decreased expression of ACSL1 mRNA CTD PMID:17547211 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of ACSL1 mRNA CTD PMID:24136188 nickel dichloride decreases expression ISO RGD:1342971 6480464 nickel chloride results in decreased expression of ACSL1 mRNA CTD PMID:17547211 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of ACSL1 mRNA CTD PMID:22110744 nicotine increases splicing ISO RGD:1342971 6480464 Nicotine results in increased splicing of ACSL1 mRNA alternative form CTD PMID:23825647 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of ACSL1 mRNA CTD PMID:24136188 obeticholic acid decreases expression ISO RGD:1342971 6480464 obeticholic acid results in decreased expression of ACSL1 mRNA CTD PMID:27939613 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of ACSL1 mRNA CTD PMID:16251485 oleic acid multiple interactions ISO RGD:1342971 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of ACSL1 mRNA, [Palmitic Acid co-treated with Oleic Acid] affects the expression of ACSL1 mRNA CTD PMID:30547786 osthole increases expression ISO RGD:1342971 6480464 osthol results in increased expression of ACSL1 mRNA CTD PMID:19682441 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ACSL1 mRNA CTD PMID:25729387 ozone decreases expression ISO RGD:737089 6480464 Ozone results in decreased expression of ACSL1 mRNA CTD PMID:12763052 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] affects the expression of ACSL1 mRNA CTD PMID:18636392 panobinostat multiple interactions ISO RGD:1342971 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL1 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1342971 6480464 panobinostat results in increased expression of ACSL1 mRNA CTD PMID:26272509 paracetamol multiple interactions ISO RGD:737089 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of ACSL1 mRNA more ... CTD PMID:17585979 , PMID:25499718 paracetamol increases expression ISO RGD:1342971 6480464 Acetaminophen results in increased expression of ACSL1 mRNA CTD PMID:22230336 , PMID:25704631 paracetamol affects expression ISO RGD:737089 6480464 Acetaminophen affects the expression of ACSL1 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of ACSL1 mRNA CTD PMID:17522070 paraquat affects expression EXP 6480464 Paraquat affects the expression of ACSL1 mRNA CTD PMID:15206577 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of ACSL1 mRNA CTD PMID:18198484 perfluorobutanesulfonic acid increases expression ISO RGD:737089 6480464 perfluorobutanesulfonic acid results in increased expression of ACSL1 mRNA CTD PMID:21705711 perfluorodecanoic acid increases expression ISO RGD:1342971 6480464 perfluorodecanoic acid results in increased expression of ACSL1 mRNA CTD PMID:23567314 perfluoroheptanoic acid increases expression ISO RGD:1342971 6480464 perfluoro-n-heptanoic acid results in increased expression of ACSL1 mRNA CTD PMID:23567314 perfluorohexanesulfonic acid increases expression ISO RGD:737089 6480464 perfluorohexanesulfonic acid results in increased expression of ACSL1 mRNA CTD PMID:21705711 perfluorohexanesulfonic acid increases expression ISO RGD:1342971 6480464 perfluorohexanesulfonic acid results in increased expression of ACSL1 mRNA CTD PMID:23567314 perfluorohexanoic acid increases expression ISO RGD:1342971 6480464 perfluorohexanoic acid results in increased expression of ACSL1 mRNA CTD PMID:23567314 perfluorononanoic acid increases expression ISO RGD:1342971 6480464 perfluoro-n-nonanoic acid results in increased expression of ACSL1 mRNA CTD PMID:23567314 perfluorooctane-1-sulfonic acid affects expression ISO RGD:737089 6480464 perfluorooctane sulfonic acid affects the expression of ACSL1 mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid increases expression ISO RGD:737089 6480464 perfluorooctane sulfonic acid results in increased expression of ACSL1 mRNA CTD PMID:20936131 , PMID:21705711 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of ACSL1 mRNA CTD PMID:18692542 perfluorooctanoic acid affects expression ISO RGD:737089 6480464 perfluorooctanoic acid affects the expression of ACSL1 mRNA CTD PMID:19429403 perfluorooctanoic acid increases expression ISO RGD:1342971 6480464 perfluorooctanoic acid results in increased expression of ACSL1 mRNA, perfluorooctanoic acid results in increased expression of ACSL1 protein CTD PMID:23567314 , PMID:26879310 perfluorooctanoic acid increases expression ISO RGD:737089 6480464 perfluorooctanoic acid results in increased expression of ACSL1 mRNA CTD PMID:18467677 more ... perfluorooctanoic acid multiple interactions ISO RGD:737089 6480464 PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of ACSL1 mRNA] CTD PMID:18467677 , PMID:20936131 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of ACSL1 mRNA CTD PMID:28511854 permethrin increases expression ISO RGD:737089 6480464 Permethrin results in increased expression of ACSL1 mRNA CTD PMID:30629241 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of ACSL1 mRNA CTD PMID:19162173 phenylmercury acetate increases expression ISO RGD:1342971 6480464 Phenylmercuric Acetate results in increased expression of ACSL1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1342971 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL1 mRNA CTD PMID:27188386 phlorizin decreases expression ISO RGD:737089 6480464 Phlorhizin results in decreased expression of ACSL1 mRNA CTD PMID:22538082 pirinixic acid multiple interactions ISO RGD:1342971 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ACSL1 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:737089 6480464 pirinixic acid results in increased expression of ACSL1 mRNA CTD PMID:15302862 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of ACSL1 mRNA CTD PMID:16940010 , PMID:19162173 pirinixic acid multiple interactions ISO RGD:737089 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ACSL1 mRNA more ... CTD PMID:16221962 more ... potassium dichromate decreases expression ISO RGD:1342971 6480464 Potassium Dichromate results in decreased expression of ACSL1 mRNA CTD PMID:17547211 pravastatin decreases expression ISO RGD:737089 6480464 Pravastatin results in decreased expression of ACSL1 mRNA CTD PMID:27225895 prednisolone increases expression ISO RGD:1342971 6480464 Prednisolone results in increased expression of ACSL1 mRNA CTD PMID:17379860 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of ACSL1 mRNA CTD PMID:19162173 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:737089 6480464 Pregnenolone Carbonitrile results in decreased expression of ACSL1 mRNA CTD PMID:20359477 pregnenolone 16alpha-carbonitrile multiple interactions ISO RGD:737089 6480464 Pregnenolone Carbonitrile inhibits the reaction [Lithocholic Acid results in decreased expression of ACSL1 mRNA] CTD PMID:20359477 progesterone multiple interactions ISO RGD:1342971 6480464 [Estradiol co-treated with Progesterone] results in increased expression of ACSL1 mRNA, [Progesterone co-treated with Estradiol] results in increased expression of ACSL1 mRNA CTD PMID:17404688 , PMID:20660070 progesterone increases expression EXP 6480464 Progesterone results in increased expression of ACSL1 mRNA CTD PMID:20726854 progesterone increases expression ISO RGD:1342971 6480464 Progesterone results in increased expression of ACSL1 mRNA CTD PMID:17404688 more ... promegestone increases expression ISO RGD:1342971 6480464 Promegestone results in increased expression of ACSL1 mRNA CTD PMID:15103026 promegestone multiple interactions ISO RGD:1342971 6480464 methoxyacetic acid promotes the reaction [Promegestone results in increased expression of ACSL1 mRNA] CTD PMID:15103026 propiconazole decreases expression ISO RGD:737089 6480464 propiconazole results in decreased expression of ACSL1 mRNA CTD PMID:22334560 protein kinase inhibitor multiple interactions ISO RGD:1342971 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of ACSL1 mRNA] CTD PMID:28003376 raloxifene multiple interactions ISO RGD:1342971 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of ACSL1 mRNA CTD PMID:19059307 SB 431542 multiple interactions ISO RGD:1342971 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 scopoletin multiple interactions EXP 6480464 Scopoletin inhibits the reaction [Ethanol results in decreased expression of ACSL1 mRNA] CTD PMID:26115886 Senkirkine decreases expression ISO RGD:1342971 6480464 senkirkine results in decreased expression of ACSL1 mRNA CTD PMID:26100227 silicon dioxide decreases expression ISO RGD:737089 6480464 Silicon Dioxide results in decreased expression of ACSL1 mRNA CTD PMID:23221170 sodium arsenite increases expression ISO RGD:1342971 6480464 sodium arsenite results in increased expression of ACSL1 mRNA CTD PMID:21457566 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of ACSL1 protein CTD PMID:29459688 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of ACSL1 mRNA CTD PMID:22110744 sodium fluoride increases expression ISO RGD:737089 6480464 Sodium Fluoride results in increased expression of ACSL1 mRNA CTD PMID:27862939 sulforaphane increases expression ISO RGD:1342971 6480464 sulforafan results in increased expression of ACSL1 mRNA CTD PMID:26833863 sulforaphane increases expression ISO RGD:737089 6480464 sulforafan results in increased expression of ACSL1 mRNA CTD PMID:30529165 sulindac multiple interactions EXP 6480464 [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of ACSL1 mRNA CTD PMID:20371263 tamoxifen multiple interactions ISO RGD:1342971 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of ACSL1 mRNA CTD PMID:19059307 tamoxifen affects expression ISO RGD:737089 6480464 Tamoxifen affects the expression of ACSL1 mRNA CTD PMID:17555576 tamoxifen affects expression ISO RGD:1342971 6480464 Tamoxifen affects the expression of ACSL1 mRNA CTD PMID:14699072 tauroursodeoxycholic acid decreases expression EXP 6480464 tauroursodeoxycholic acid results in decreased expression of ACSL1 mRNA CTD PMID:15885361 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of ACSL1 mRNA CTD PMID:21515302 tetrachloroethene increases expression ISO RGD:737089 6480464 Tetrachloroethylene results in increased expression of ACSL1 mRNA CTD PMID:28973375 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of ACSL1 mRNA CTD PMID:15963342 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACSL1 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:737089 6480464 Carbon Tetrachloride results in decreased expression of ACSL1 mRNA CTD PMID:27339419 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ACSL1 mRNA CTD PMID:17522070 , PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of ACSL1 mRNA CTD PMID:16239168 tetracycline increases expression ISO RGD:737089 6480464 Tetracycline results in increased expression of ACSL1 mRNA CTD PMID:16917069 tetracycline decreases expression ISO RGD:737089 6480464 Tetracycline results in decreased expression of ACSL1 mRNA CTD PMID:24489787 tetracycline decreases expression EXP 6480464 Tetracycline results in decreased expression of ACSL1 mRNA CTD PMID:17522070 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ACSL1 mRNA CTD PMID:28943392 titanium dioxide decreases expression ISO RGD:737089 6480464 titanium dioxide results in decreased expression of ACSL1 mRNA CTD PMID:23557971 titanium dioxide affects expression ISO RGD:737089 6480464 titanium dioxide affects the expression of ACSL1 mRNA CTD PMID:17656681 tolcapone affects binding EXP 6480464 tolcapone binds to ACSL1 protein CTD PMID:19783845 tolcapone decreases expression ISO RGD:1342971 6480464 tolcapone results in decreased expression of ACSL1 mRNA, tolcapone results in decreased expression of ACSL1 protein CTD PMID:29688484 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of ACSL1 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of ACSL1 mRNA CTD PMID:25729387 tributylstannane increases expression ISO RGD:737089 6480464 tributyltin results in increased expression of ACSL1 mRNA CTD PMID:23428407 trichloroethene increases expression ISO RGD:737089 6480464 Trichloroethylene results in increased expression of ACSL1 mRNA CTD PMID:19254012 , PMID:28973375 trichostatin A increases expression ISO RGD:1342971 6480464 trichostatin A results in increased expression of ACSL1 mRNA CTD PMID:24935251 triclosan decreases expression ISO RGD:1342971 6480464 Triclosan results in decreased expression of ACSL1 mRNA CTD PMID:30510588 troglitazone increases expression ISO RGD:737089 6480464 troglitazone results in increased expression of ACSL1 mRNA CTD PMID:12732648 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of ACSL1 mRNA, troglitazone results in increased expression of ACSL1 protein CTD PMID:21315101 more ... troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of ACSL1 mRNA CTD PMID:9452481 tungsten decreases expression ISO RGD:737089 6480464 Tungsten results in decreased expression of ACSL1 mRNA CTD PMID:30912803 tungsten(4+) decreases expression ISO RGD:737089 6480464 Tungsten results in decreased expression of ACSL1 mRNA CTD PMID:30912803 valproic acid increases expression ISO RGD:737089 6480464 Valproic Acid results in increased expression of ACSL1 mRNA CTD PMID:24489787 valproic acid multiple interactions ISO RGD:1342971 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACSL1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1342971 6480464 Valproic Acid results in increased expression of ACSL1 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1342971 6480464 Valproic Acid affects the expression of ACSL1 mRNA CTD PMID:25979313 vancomycin increases expression ISO RGD:737089 6480464 Vancomycin results in increased expression of ACSL1 mRNA CTD PMID:18930951 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of ACSL1 mRNA CTD PMID:19015723 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of ACSL1 mRNA CTD PMID:22570695 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of ACSL1 mRNA CTD PMID:27225895 zaragozic acid A affects expression ISO RGD:737089 6480464 squalestatin 1 affects the expression of ACSL1 mRNA CTD PMID:27225895 zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of ACSL1 mRNA CTD PMID:12672911 , PMID:15671213 zinc atom multiple interactions ISO RGD:737089 6480464 [Zinc deficiency co-treated with Ethanol] results in increased expression of ACSL1 mRNA CTD PMID:24155903 zinc atom decreases expression ISO RGD:737089 6480464 Zinc deficiency results in decreased expression of ACSL1 mRNA CTD PMID:24155903 zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of ACSL1 mRNA CTD PMID:12672911 , PMID:15671213 zinc(0) multiple interactions ISO RGD:737089 6480464 [Zinc deficiency co-treated with Ethanol] results in increased expression of ACSL1 mRNA CTD PMID:24155903 zinc(0) decreases expression ISO RGD:737089 6480464 Zinc deficiency results in decreased expression of ACSL1 mRNA CTD PMID:24155903 zoledronic acid decreases expression ISO RGD:1342971 6480464 Zoledronic Acid results in decreased expression of ACSL1 mRNA, Zoledronic Acid results in decreased expression of ACSL1 protein CTD PMID:25596134 , PMID:28871336
Gene-Chemical Interaction Annotations
